aTYR PHARMA INC - ATYR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 04, 2026 | President and CEO | M | D | 10,375.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 04, 2026 | President and CEO | S | D | 3,745.0 | 0.976 | 3,655.12 | 153,553.0 | View | |
| Feb 04, 2026 | President and CEO | M | A | 10,375.0 | — | — | 157,298.0 | View | |
| Feb 04, 2026 | Chief Financial Officer | M | D | 3,750.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 04, 2026 | Chief Financial Officer | S | D | 1,558.0 | 0.976 | 1,520.61 | 37,296.0 | View | |
| Feb 04, 2026 | Chief Financial Officer | M | A | 3,750.0 | — | — | 38,854.0 | View | |
| Feb 04, 2026 | General Counsel | M | D | 2,687.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 04, 2026 | General Counsel | S | D | 1,118.0 | 0.9761 | 1,091.28 | 33,124.0 | View | |
| Feb 04, 2026 | General Counsel | M | A | 2,687.0 | — | — | 34,242.0 | View | |
| Jan 09, 2026 | President and CEO | A | A | 1,500,000.0 | 0.0 | 0.0 | 1,500,000.0 | View | |
| Jan 09, 2026 | Chief Financial Officer | A | A | 412,500.0 | 0.0 | 0.0 | 412,500.0 | View | |
| Jan 09, 2026 | General Counsel | A | A | 412,500.0 | 0.0 | 0.0 | 412,500.0 | View |